Skip to main content
  • MEETINGS
  • JOBS/RFPs
  • FUNDING
 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Home

State Stem Cell Agency Governing Board Meeting Transcript 5-25-10

This is an uncertified HTML copy of the transcript.  Click
here for a certified PDF transcript.



BEFORE THE

INDEPENDENT CITIZENS' OVERSIGHT COMMITTEE
TO THE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
ORGANIZED PURSUANT TO THE
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

SPECIAL MEETING










LOCATION: AS INDICATED ON THE AGENDA






DATE: TUESDAY, MAY 25, 2010
8 A.M.




REPORTER: BETH C. DRAIN, CSR
CSR. NO. 7152




BRS FILE NO.: 87444










                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   





I N D E X


ITEM DESCRIPTION PAGE NO.

1. CALL TO ORDER 3

2. ROLL CALL 3

3. CONSIDERATION OF UPDATE AND 6
POSITION ON SB 1064 (ALQUIST).

4. ADDITIONAL ITEM: 26

CONSIDERATION OF FUNDING FOR PARTICIPATION IN THE
ISSCR ANNUAL MEETING FOR PATIENT ADVOCATES, CIRM
TRAINING GRANTS PARTICIPANTS (CIRM SCHOLARS),
BRIDGES TO STEM CELL RESEARCH PARTICIPANTS (MASTERS
DEGREE CANDIDATES) AND RESEARCHERS ON CIRM-FUNDED
GRANTS (POST-DOC RESEARCHERS AND GRADUATE DEGREE
CANDIDATES), RESTRICTED TO APPLICANTS NOT ALREADY
REGISTERED

PUBLIC COMMENT NONE



























2

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 TUESDAY, MAY 25, 2010

2 8 A.M.

3

4 MS. KING: OKAY. THANK YOU, EVERYBODY,

5 FOR JOINING THIS MORNING. THIS IS MELISSA IN SAN

6 FRANCISCO, AND I AM GOING TO CALL THE ROLL. I KNOW

7 I HAVE DONALD DAFOE FOR RICARDO AZZIZ, CORRECT?

8 DR. DAFOE: YES, CORRECT.

9 MS. KING: ROBERT BIRGENEAU. FLOYD BLOOM.

10 DR. BLOOM: HERE.

11 MS. KING: DAVID BRENNER. WILLIAM BRODY.

12 DR. BRODY: HERE.

13 MS. KING: JACOB LEVIN FOR SUSAN BRYANT.

14 DR. LEVIN: HERE.

15 MS. KING: MARCY FEIT. MICHAEL FRIEDMAN.

16 LEEZA GIBBONS.

17 MS. GIBBONS: HERE.

18 MS. KING: MICHAEL GOLDBERG. SAM HAWGOOD.

19 BOB KLEIN. SHERRY LANSING. GERALD LEVEY.

20 DR. LEVEY: HERE.

21 MS. KING: TED LOVE.

22 DR. LOVE: HERE.

23 MS. KING: ED PENHOET.

24 DR. PENHOET: HERE.

25 MS. KING: PHIL PIZZO. CLAIRE POMEROY.




3

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 FRANCISCO PRIETO. CARMEN PULIAFITO. ROBERT QUINT.

2 JEANNIE FONTANA FOR JOHN REED.

3 DR. FONTANA: HERE.

4 MS. KING: DUANE ROTH.

5 MR. ROTH: HERE.

6 MS. KING: JOAN SAMUELSON. DAVID

7 SERRANO-SEWELL.

8 MR. SERRANO-SEWELL: HERE.

9 MS. KING: JEFF SHEEHY.

10 MR. SHEEHY: HERE.

11 MS. KING: JON SHESTACK.

12 MR. SHESTACK: HERE.

13 MS. KING: OSWALD STEWARD. AND ART

14 TORRES.

15 MR. TORRES: HERE.

16 MS. KING: ALL RIGHT. SO WE DON'T QUITE

17 HAVE A QUORUM, SENATOR TORRES, BUT I SUGGEST WE GET

18 STARTED AND MAYBE --

19 MR. TORRES: I THOUGHT THIS WAS A BOARD

20 MEETING.

21 MS. KING: RIGHT. BUT I'M ASKING YOU AS

22 VICE CHAIR, WE DON'T YET HAVE OUR CHAIR, IF YOU

23 WOULDN'T MIND.

24 MR. TORRES: I THINK BOB JUST GOT ON.

25 MS. KING: WHO JUST JOINED? HOW ABOUT,




4

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MR. HARRISON, COULD YOU PLEASE WALK US THROUGH --

2 MR. TORRES: NO. NO. NO. HAVE WE MADE

3 AND ATTEMPT TO GET BOB ON THE LINE?

4 MS. KING: WE HAVE SEVERAL TIMES.

5 MR. TORRES: OKAY. AND WHAT TIME DO WE

6 HAVE? LET'S WAIT A FEW MINUTES.

7 MS. KING: SO THANK YOU AGAIN TO EVERYBODY

8 WHO'S ON THE PHONE. WE'RE GOING TO GIVE OTHERS A

9 COUPLE MORE MINUTES TO JOIN THE CALL AS WE HAVE BEEN

10 DOING FOR A FEW MINUTES ALREADY. SO THANK YOU ALL

11 FOR YOUR PATIENCE.

12 (PAUSE IN PROCEEDINGS.)

13 VICE CHAIRMAN TORRES: THIS IS ART TORRES.

14 I'M GOING TO START THE MEETING WHILE WE'RE WAITING

15 FOR BOB TO GET ON THE PHONE. I WANT TO THANK, FIRST

16 OF ALL, THE PARTICIPANTS IN THIS LEGISLATIVE

17 APPROACH THAT WE HAVE TRIED TO TAKE. FIRST OF ALL,

18 I WANT TO THANK DR. ALAN TROUNSON, WHO'S WITH US;

19 BOB KLEIN, DUANE ROTH, WHO WAS PIVOTAL IN OUR

20 NEGOTIATIONS, AND OUR TWO EXCELLENT NEGOTIATORS,

21 MR. JAMES HARRISON AND MR. SCOTT TOCHER AND ALSO THE

22 INPUT OF ELONA BAUM AND JOHN ROBSON. AND OBVIOUSLY

23 BOB KLEIN WHO WAS INSTRUMENTAL AT THE OUTSET OF

24 THESE NEGOTIATIONS.

25 I ALSO WANT TO GIVE A SPECIAL THANKS TO




5

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 SENATOR ELAINE ALQUIST AND HER STAFF, TO SENATOR

2 DARRELL STEINBERG, WHO IS PRESIDENT PRO TEM OF THE

3 SENATE, WHO BROUGHT US TOGETHER INITIALLY A FEW

4 WEEKS AGO TO HELP FERRET OUT A COMPROMISE, TO

5 SENATOR DEAN FLORES AND HIS STAFF, WHO WAS VERY,

6 VERY HELPFUL TO US IN WORKING WITH SENATOR STEINBERG

7 AND WITH SENATOR ALQUIST AND WITH SENATOR KEHOE, WHO

8 IS CHAIR OF THE APPROPRIATIONS COMMITTEE, AND HER

9 STAFF AS WELL.

10 DUANE WAS VERY INSTRUMENTAL IN HAVING

11 EXCELLENT CONVERSATIONS WITH SENATOR KEHOE AND HER

12 STAFF. AND I BELIEVE THAT WE HAVE COME TOGETHER

13 WITH A COMPROMISE THAT WE WANTED TO PRESENT TO THE

14 BOARD FOR OUR SUPPORT AS THIS LEGISLATION MOVES

15 THROUGH THE PROCESS.

16 SO I WANT TO TURN IT OVER NOW TO JAMES

17 HARRISON WHO WILL GO OVER THE POINTS OF THE

18 LEGISLATION, AND THEN WE CAN GET INTO A DISCUSSION.

19 JAMES.

20 MR. HARRISON: GOOD MORNING, EVERYONE. AS

21 YOU MAY RECALL, SB 1064 BEGAN AS A RATHER BROAD

22 APPROACH AT AMENDING A VARIETY OF PROVISIONS OF PROP

23 71. THROUGH OUR NEGOTIATION, WE ARRIVED AT A

24 COMPROMISE THAT IS SIGNIFICANTLY NARROWER IN SCOPE

25 THAN WHAT THE BILL BEGAN AS. AND IN PARTICULAR, THE




6

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 BILL DOES NOT ADDRESS A NUMBER OF PROVISIONS THAT

2 HAD EARLIER BEEN INCLUDED, INCLUDING MODIFYING THE

3 TERMS OF THE CHAIR AND VICE CHAIR, CODIFYING CALRX

4 PRICING WHICH IS PART OF OUR IP REGULATIONS,

5 EXPANDING THE JURISDICTION OF CITIZENS FINANCIAL

6 ACCOUNTABILITY OVERSIGHT COMMITTEE, MODIFYING THE

7 DUTIES OF THE CHAIR AND THE PRESIDENT, ELIMINATING

8 THE PREAPPLICATION PROCESS, AND INCLUDING A

9 DEFINITION OF ADMINISTRATIVE COSTS. ALL OF THOSE

10 TOPICS ARE NOW OFF THE TABLE AND OUTSIDE THE SCOPE

11 OF THE BILL.

12 LET ME BRIEFLY DESCRIBE WHAT SB 1064 WOULD

13 DO IN ITS CURRENT FORM. FIRST, IT WOULD REMOVE THE

14 50-EMPLOYEE CAP UNDER WHICH CIRM CURRENTLY OPERATES,

15 BUT CONTINUE TO REQUIRE THE AGENCY TO OPERATE WITHIN

16 THE 6-PERCENT OVERALL CAP OF ITS ADMINISTRATIVE

17 EXPENDITURES.

18 SECOND, IT WOULD AUTHORIZE THE BOARD TO

19 SET A DAILY COMPENSATION RATE AS OPPOSED TO A PER

20 DIEM FOR THE PATIENT ADVOCATES ON THE BOARD WHO

21 SERVE AS MEMBERS OF THE WORKING GROUP. CURRENTLY

22 THEY ARE ENTITLED TO A PER DIEM OF $116 PER DAY FOR

23 THE MANY HOURS OF WORK THEY PUT INTO THEIR EFFORTS

24 ON THE WORKING GROUPS.

25 THIRD, THE BILL WOULD REQUIRE THAT CIRM'S




7

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 INTELLECTUAL PROPERTY REGULATIONS INCLUDE A

2 REQUIREMENT THAT GRANTEES AND EXCLUSIVE LICENSEES

3 SUBMIT A PLAN TO CIRM TO AFFORD ACCESS TO A DRUG

4 THAT IS IN WHOLE OR IN PART THE RESULT OF

5 CIRM-FUNDED RESEARCH TO CALIFORNIANS WHO HAVE NO

6 OTHER MEANS TO PURCHASE THE DRUG. LIKE OUR CURRENT

7 REGULATIONS, WHICH INCLUDE THE REQUIREMENT, THE PLAN

8 WOULD HAVE TO BE CONSISTENT WITH INDUSTRY STANDARDS

9 AT THE TIME OF COMMERCIALIZATION IN CALIFORNIA,

10 ACCOUNTING FOR THE SIZE OF THE MARKET FOR THE DRUG

11 AND THE RESOURCES OF THE GRANTEE OR EXCLUSIVE

12 LICENSEE.

13 IMPORTANTLY, THE BOARD WOULD RETAIN THE

14 AUTHORITY TO IMPLEMENT THIS REQUIREMENT THROUGH

15 REGULATIONS AND ALSO TO GRANT A WAIVER TO THE ACCESS

16 PLAN REQUIREMENT IF THE BOARD WERE TO DETERMINE THAT

17 IN THE ABSENCE OF A WAIVER DEVELOPMENT AND BROAD

18 DELIVERY OF THE DRUG WOULD BE UNREASONABLY HINDERED

19 OR THAT A WAIVER WOULD PROVIDE BENEFITS THAT EQUAL

20 OR EXCEED THE BENEFITS THAT WOULD OTHERWISE FLOW

21 FROM THE ACCESS PLAN. SO THE IMPORTANT THING ABOUT

22 THIS PARTICULAR PROVISION, THOUGH IT CODIFIES PART

23 OF OUR REGULATIONS, IS THAT IT MAINTAINS SIGNIFICANT

24 FLEXIBILITY FOR THE BOARD GOING FORWARD.

25 THE BILL WOULD ALSO CODIFY CIRM'S CURRENT




8

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 REVENUE SHARING REQUIREMENTS IN LARGE PART. IT

2 WOULD REQUIRE THAT OUR IP REGULATIONS INCLUDE A

3 REQUIREMENT THAT CIRM'S GRANTEES SHARE A FRACTION OF

4 THE REVENUES THEY RECEIVE FROM LICENSING OR

5 SELF-COMMERCIALIZING AN INVENTION OR TECHNOLOGY THAT

6 ARISES FROM CIRM-FUNDED RESEARCH. AND IT WOULD

7 REQUIRE THAT THOSE FUNDS GO TO THE STATE GENERAL

8 FUND. IT WOULD ALSO IN LARGE PART, AS I SAID,

9 CODIFY OUR EXISTING FORMULAS. HOWEVER, IT WOULD

10 PROVIDE THE BOARD WITH CONTINUED FLEXIBILITY TO

11 MODIFY THOSE FORMULAS IN THE FUTURE IF THE BOARD

12 DETERMINES IT'S NECESSARY TO RESTRIKE THE BALANCE.

13 AS YOU RECALL, PROP 71 REQUIRES THAT THE

14 IP REGULATIONS BALANCE THE INTEREST OF THE STATE IN

15 GETTING A RETURN ON ITS INVESTMENT WITH THE NEED TO

16 ENSURE THAT ESSENTIAL MEDICAL RESEARCH, INCLUDING

17 THERAPY DEVELOPMENT AND THE BROAD DELIVERY OF

18 THERAPIES TO PATIENTS, IS NOT UNREASONABLY HINDERED.

19 THE SCOPE OF THE STATUTE IS NOT AS BROAD

20 AS OUR EXISTING REGULATIONS. FOR EXAMPLE, OUR

21 REGULATIONS REQUIRE THAT COLLABORATORS SHARE A

22 FRACTION OF THE REVENUES THEY RECEIVE FROM

23 CIRM-FUNDED INVENTIONS. BUT THE STATUTE IS

24 PERMISSIVE AND IT PERMITS SIMPLY THE FLEXIBILITY TO

25 ADOPT REGULATIONS THAT EXCEED THE MINIMUM




9

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 REQUIREMENTS OF THE STATUTE.

2 SO, AGAIN, THE IMPORTANT ASPECT OF THIS

3 PROVISION IS THAT WHILE IT CODIFIES MUCH OF OUR

4 REGULATIONS REGARDING REVENUE SHARING, IT PERMITS

5 THE BOARD TO CONTINUE TO EXERCISE DISCRETION IN THE

6 FUTURE TO MODIFY THOSE FORMULAS IN ORDER TO ENSURE

7 THAT CIRM IS ABLE TO ACHIEVE THE GOALS OF PROP 71.

8 NEXT, THE BILL WOULD ELIMINATE WHAT IS A

9 CURRENT 15-MEMBER CAP ON SCIENTIFIC MEMBERS OF THE

10 GRANTS WORKING GROUP. AS YOU KNOW, CURRENTLY WE

11 HAVE BOTH REGULAR MEMBERS AND ALTERNATE MEMBERS.

12 THIS AMENDMENT WOULD PERMIT US TO ELIMINATE THAT

13 DISTINCTION WHILE MAINTAINING THE 15-SCIENTIST

14 MEMBER LIMIT ON EACH PEER REVIEW PANEL.

15 ONE OF THE MORE SIGNIFICANT PROVISIONS OF

16 THE BILL WOULD REQUIRE CIRM TO ENGAGE AN

17 ADMINISTRATIVE PERFORMANCE AUDIT EVERY THREE YEARS

18 BEGINNING IN FISCAL YEAR 2010-2011. THIS FISCAL

19 AUDIT WOULD COVER CIRM'S OPERATIONS AND POLICIES TO

20 EVALUATE WHETHER THE AGENCY IS APPLYING BEST

21 PRACTICES AND WHETHER OR NOT IT'S COMPLYING WITH ITS

22 OWN POLICIES AND PROCEDURES.

23 THIS REVIEW WOULD NOT REQUIRE A REVIEW OF

24 SCIENTIFIC PERFORMANCE, ALTHOUGH THAT COULD

25 CERTAINLY BE INCLUDED WITHIN THE SCOPE OF ANY AUDIT




10

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 THE AGENCY COMMISSIONS.

2 THE BILL WOULD ALSO CODIFY ONE OF OUR

3 CURRENT PRACTICES, WHICH IS TO POST VOTE TALLIES

4 ALONG WITH RECUSALS FOR EACH BOARD MEETING. IT

5 WOULD CODIFY SOMETHING THAT'S ALREADY UNDER WAY,

6 WHICH IS TRANSITION PLANNING; THAT IS, PLANNING FOR

7 THE EVENTUAL EXPIRATION OF BOND FUNDING, WHICH THE

8 AGENCY IS ALREADY ENGAGED IN. AND IT WOULD REQUIRE

9 US TO PRODUCE A REPORT REGARDING THE FUTURE PLANS BY

10 JANUARY 31ST, 2012.

11 AND FINALLY, THE BILL WOULD REQUIRE THE

12 AGENCY, THE BOARD, TO ENGAGE IN SUCCESSION PLANNING

13 TO ASSESS ITS LEADERSHIP NEEDS IN LIGHT OF THE

14 UPCOMING TRANSITION WITH THE EXPIRATION OF BOARD

15 MEMBER TERMS, INCLUDING THE CHAIR AND VICE CHAIRS.

16 THE EVALUATION SUBCOMMITTEE HAS ALREADY BEGUN TO

17 DISCUSS THESE ISSUES. BOTH THE EVALUATION

18 SUBCOMMITTEE AND THE BOARD WILL HAVE AN OPPORTUNITY

19 TO DISCUSS THESE ISSUES MORE IN THE FUTURE.

20 THERE ARE A COUPLE OF TECHNICAL ISSUES

21 THAT WE RAISED WITH THE AUTHOR, SENATOR ALQUIST, AND

22 SHE IS SUPPORTIVE OF OUR REQUEST FOR AMENDMENTS TO

23 CORRECT THOSE ISSUES. HOWEVER, GIVEN THE TIMING,

24 IT'S LIKELY THAT THOSE AMENDMENTS WILL NOT BE MADE

25 UNTIL THE BILL REACHES THE ASSEMBLY. BUT SENATOR




11

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 ALQUIST IS SUPPORTIVE.

2 SO WHAT WE WOULD RECOMMEND IS THAT THE

3 BOARD ENDORSE THE BILL, BUT RESERVE THE RIGHT TO

4 REVIEW FOR TECHNICAL PROFICIENCY.

5 VICE CHAIRMAN TORRES: ALL RIGHT. THANK

6 YOU VERY MUCH, JAMES. SHERRY LANSING COULD NOT BE

7 WITH US TODAY, BUT SHE AND I SPOKE LAST EVENING AND

8 SHE SUPPORTS THE RECOMMENDATION ON THIS LEGISLATION.

9 AGAIN, MY THANKS TO MELISSA KING AND NICK

10 WARSHAW FOR HANDLING ALL THE LOGISTICS OF ALL OF

11 THESE DISCUSSIONS AND MEETINGS IN SACRAMENTO. THANK

12 YOU VERY MUCH FOR YOUR HELP.

13 ANY COMMENTS FROM MEMBERS OF THE BOARD?

14 CHAIRMAN KLEIN: ART, THIS IS BOB KLEIN.

15 I WOULD LIKE TO COMMEND YOUR LEADERSHIP AND DUANE

16 ROTH'S TREMENDOUS COMMITMENT TO THIS EFFORT. AND

17 BOTH JAMES HARRISON AND SCOTT TOCHER FOR THEIR DEEP

18 COMMITMENT TO THE PROCESS WHICH WAS EXTREMELY

19 TIME-CONSUMING AND INTENSE.

20 VICE CHAIRMAN TORRES: I GIVE THE

21 CHAIRMANSHIP BACK TO YOU, BOB.

22 CHAIRMAN KLEIN: IN LOOKING AT THIS, THIS

23 IS A PROCESS THAT HAS TAKEN A GREAT DEAL OF TIME AND

24 MERGED HOPEFULLY A VERY POSITIVE RELATIONSHIP WITH

25 MEMBERS OF THE LEGISLATURE. CERTAINLY THE AUTHOR,




12

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 SENATOR ALQUIST, HAS WORKED WELL WITH US AT THIS

2 POINT. THE SENATE PRO TEM DARRELL STEINBERG, AS

3 MENTIONED, HAS BEEN A VERY IMPORTANT LEADER IN THIS

4 PROCESS ALONG WITH THEIR STAFFS.

5 AND I WOULD LIKE TO GET COMMENTS FROM

6 OTHER MEMBERS AND THEIR LOCATIONS. AND, MELISSA,

7 COULD YOU POLL THE LOCATIONS SO WE CAN SEE WHAT

8 THOSE COMMENTS MIGHT BE?

9 MS. KING: ACTUALLY WHAT I'D LIKE TO DO

10 BEFORE THAT, IF I COULD, CHAIRMAN KLEIN, IS ASK

11 ANYBODY WHO'S JOINED THE MEETING SINCE THE ROLL CALL

12 AND, THEREFORE, HASN'T BEEN CALLED OR RECOGNIZED AS

13 HAVING JOINED THE MEETING, IF YOU COULD LET ME KNOW

14 WHO YOU ARE THAT, WOULD BE GREAT.

15 MS. SAMUELSON: JOAN SAMUELSON.

16 MS. KING: THANK YOU, JOAN. ANYBODY ELSE?

17 DR. BIRGENEAU: BOB BIRGENEAU. I JUST

18 JOINED THE CALL A FEW MINUTES AGO.

19 MS. KING: OKAY. GREAT. THANKS, DR.

20 BIRGENEAU.

21 MR. TORRES: DR. TROUNSON HAS JOINED US

22 SINCE THE ROLL CALL AS WELL.

23 DR. AZZIZ: AND YOU TOOK MY NAME DOWN,

24 MELISSA, RICARDO?

25 MS. KING: YES. THANK YOU VERY MUCH, DR.




13

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 AZZIZ. ALL RIGHT.

2 WHY DON'T WE JUST ASK WHOEVER HAS A

3 COMMENT TO MAKE A COMMENT.

4 DR. DAFOE: MELISSA, SINCE DR. AZZIZ IS ON

5 THE CALL, I WILL BAIL OUT BECAUSE I'M THE ALTERNATE.

6 MS. KING: THAT IS CORRECT. WE CAN ONLY

7 COUNT ONE OF YOU AS PRESENT; BUT DR. DAFOE, WE

8 APPRECIATE YOU BEING HERE. AND IF YOU WOULD LIKE TO

9 STAY ON THE LINE AND SHOULD YOU HAVE A COMMENT,

10 YOU'RE MORE THAN WELCOME TO MAKE A COMMENT.

11 DR. DAFOE: ALL RIGHT. THANK YOU.

12 MS. SAMUELSON: I'VE GOT A QUESTION FOR

13 JAMES. THIS IS JOAN.

14 MR. HARRISON: SURE.

15 MS. SAMUELSON: COULD YOU JUST REPEAT WHAT

16 THE TERMS OF THE LIFTING OF THE 15-MEMBER CAP ON THE

17 WORKING GROUP WAS ABOUT?

18 MR. HARRISON: YES. SO AS YOU KNOW, JOAN,

19 CURRENTLY WE HAVE 15 -- WE'RE LIMITED TO 15 REGULAR

20 MEMBERS OF THE GRANTS WORKING GROUP, 15 SCIENTIFIC

21 MEMBERS. BECAUSE OUR NEEDS ARE GREATER THAN 15 WHO

22 CAN SERVE ON ALL THE PEER REVIEW PANELS THAT WE NEED

23 IN ORDER TO PROCESS GRANTS, WE RELY ON ALTERNATES

24 AND SPECIALISTS AS WELL. WHAT THIS BILL WOULD DO

25 WOULD ESSENTIALLY BE TO ALLOW US TO HAVE A LARGER




14

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 POOL OF SCIENTISTS WHO WE CALL REGULAR MEMBERS,

2 ALTHOUGH EACH PEER REVIEW PANEL WOULD CONTINUE TO BE

3 COMPRISED OF ONLY 15 SCIENTISTS AND THE PATIENT

4 ADVOCATES.

5 CHAIRMAN KLEIN: JOAN, THIS BOB. THIS

6 DOES NOT SUBSTANTIVELY CHANGE OUR PROCESS. WHAT IT

7 MEANS, THOUGH, IS THAT INSTEAD OF THE ADDITIONAL

8 MEMBERS BEING ALTERNATES, THEY WOULD BE CONSIDERED

9 FULL MEMBERS. BUT IT DOESN'T CHANGE THE FACT THAT

10 THERE WILL BE 15 SCIENTISTS SO THAT THE RATIO OF

11 SCIENTISTS TO PATIENT ADVOCATES ON ANY PEER REVIEW

12 DOES NOT CHANGE. THE STRUCTURE REMAINS INTACT AS

13 ENVISIONED BY THE INITIATIVE.

14 MS. SAMUELSON: IT CHANGES IT FOR OTHER

15 PURPOSES OTHER THAN PEER REVIEW AND PROGRAMMATIC

16 REVIEW. AND DOES THIS MAKE THE CHANGE, OR DOES IT

17 PERMIT THE WORKING GROUPS AND THE BOARD TO DO SO?

18 MR. HARRISON: NO. CURRENTLY PROP 71

19 SPECIFIES THAT THERE ARE ONLY 15 SCIENTIFIC MEMBERS

20 OF THE GRANTS WORKING GROUP. THIS WOULD REMOVE THAT

21 LIMIT, SO THERE WOULD BE A MINIMUM OF 15 SCIENTIFIC

22 MEMBERS OF THE GRANTS WORKING GROUP. THE AGENCY AND

23 THE BOARD CAN DESIGNATE ADDITIONAL ALTERNATES AS

24 REGULAR MEMBERS UNDER THIS PROVISION, BUT THE

25 LEGISLATION WOULD LIFT THAT CAP, AGAIN, WHILE




15

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MAINTAINING THE CURRENT COMPOSITION OF EACH PEER

2 REVIEW PANEL OF 15 SCIENTIFIC MEMBERS AND PATIENT

3 ADVOCATES.

4 MS. SAMUELSON: OKAY.

5 DR. PRIETO: I HAD A QUESTION FOR JAMES

6 AND MAYBE JUST A CLARIFICATION. WHAT IS THE IMPACT

7 OF THE CHANGE IN THE STAFFING CAP FOR THE AGENCY IF

8 WE'RE STILL UNDER THE 6-PERCENT CEILING?

9 PRACTICALLY SPEAKING, HOW MUCH MORE STAFF WOULD THAT

10 ALLOW US TO HIRE?

11 MR. HARRISON: WELL, I WILL TURN TO JOHN

12 ROBSON TO ANSWER THAT QUESTION. I WILL POINT OUT

13 THAT WE'VE BEEN OPERATING AT SIGNIFICANTLY UNDER THE

14 6-PERCENT CAP SINCE THE AGENCY'S INCEPTION.

15 DR. ROBSON: SO WE'VE DONE SOME RESEARCH

16 INTO THIS. WE'VE DONE SOME MODELING. AND WE THINK

17 WE WOULD GO TO SOMEWHERE BETWEEN 55 AND 60 WE WOULD

18 NEED TO DO. IF WE GET ABOVE 60, WE HAVE PROBLEMS

19 FINDING SPACE FOR EVERYONE TO SIT IN OUR OFFICE, AND

20 IT WOULD THEN SHORTEN THE LIFE SPAN OF THE 6 PERCENT

21 WE HAVE IN OVERHEAD IN THAT WE WOULD RUN INTO A

22 MISMATCH IF WE WOULD RUN OUT OF OVERHEAD BEFORE WE

23 RUN OUT OF MONEY TO ALLOCATE TOWARD GRANTS.

24 CHAIRMAN KLEIN: DR. PRIETO, TO THE EXTENT

25 THAT THERE ARE CONTRIBUTIONS WHICH WE'VE RECEIVED IN




16

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 THE PAST, THIS IS, OF COURSE, BOB KLEIN SPEAKING, WE

2 COULD USE THOSE TO COVER PART OF THE COST OF THE

3 ADDITIONAL STAFF. SO WE'RE REMAINING AS WE ALWAYS

4 HAVE AS SET UP BY THE INITIATIVE CONSTRAINED BY 6

5 PERCENT IN STATE FUNDS, BUT CONTRIBUTIONS TO THE

6 AGENCY CAN BE USED TO SUPPORT THIS ADDITIONAL STAFF.

7 DR. PRIETO: AS WE DID IN THE EARLY DAYS.

8 CHAIRMAN KLEIN: RIGHT.

9 DR. PRIETO: A SEPARATE QUESTION FOR

10 JAMES, I THINK, ABOUT THE IP WORDING. DOES THE

11 WORD -- THE WAY YOU READ IT TO US, DOES THE WORDING

12 ACTUALLY INCLUDE DRUG, OR IS IT MORE EXPANSIVE, I

13 GUESS? OBVIOUSLY WE'RE NOT NECESSARILY THINKING

14 ABOUT DRUGS IN CELLULAR THERAPIES AND OTHER

15 PRODUCTS.

16 MR. HARRISON: THE WORDING DOES INCLUDE

17 THE TERM "DRUG" AS DO OUR REGULATIONS. HOWEVER,

18 WHAT'S REALLY CRITICAL IS THAT THE STATUTE

19 AUTHORIZES THE BOARD TO ADOPT REGULATIONS TO

20 IMPLEMENT THIS PROVISION INCLUDING SPECIFICALLY

21 DEFINING THE TERMS THAT ARE USED. FOR EXAMPLE, ONE

22 OF THE TERMS THAT'S USED IS TO MAKE THESE DRUGS

23 AVAILABLE TO CALIFORNIANS WITH NO MEANS. BOTH THOSE

24 TERMS, A DRUG, WHICH IS CURRENTLY DEFINED IN OUR

25 REGULATIONS AS CALIFORNIANS WITH NO MEANS, WOULD BE




17

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 DEFINED THROUGH REGULATORY EFFORTS. AND BY THE WAY,

2 OUR CURRENT REGULATORY DEFINITION OF DRUG INCLUDES

3 THERAPIES.

4 DR. PRIETO: OKAY.

5 MS. SAMUELSON: JAMES, AS FOLLOW-UP ON

6 THAT FROM JOAN. DOES THE STATUTE CHANGE THE LAW ON

7 THE PRICING AUTOMATICALLY, OR DOES IT PERMIT US

8 TO DO SO?

9 MR. HARRISON: THE STATUTE DOES NOT

10 ADDRESS THE CALRX ISSUE AT ALL. OUR REGULATIONS

11 CONTINUE TO ADDRESS IT, AND THE BOARD WOULD RETAIN

12 ITS FULL AUTHORITY TO MODIFY THAT IN THE FUTURE IF

13 IT CHOSE TO DO SO. IT'S NOT ADDRESSED BY THE BILL.

14 MS. SAMUELSON: ALL RIGHT.

15 MS. GIBBONS: THIS IS LEEZA WITH A

16 QUESTION ABOUT THE CHANGES IN THIS REGARDING OUR

17 LEADERSHIP, THE CHAIRPERSON AND THE VICE

18 CHAIRPERSON. I'M LOOKING AT THE TERMS. I GOT THAT.

19 DOES THIS ACCOMMODATE OUR CURRENT SITUATION WITH TWO

20 VICE CHAIRS IF WE GO FORWARD?

21 MR. HARRISON: THE BILL IS SILENT ON THAT

22 ISSUE ENTIRELY. THE TWO VICE CHAIR MODEL THAT WE'VE

23 DEVELOPED WAS DEVELOPED THROUGH OUR BYLAWS WHICH THE

24 BOARD WILL CONTINUE TO HAVE FULL AUTHORITY OVER. SO

25 THIS BILL DOESN'T IN ANY WAY IMPEDE THE BOARD IN




18

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 THAT AREA.

2 MS. GIBBONS: THANK YOU.

3 DR. LOVE: I DIDN'T HAVE A QUESTION, BUT I

4 DID HAVE A COMMENT THAT I DIDN'T PARTICIPATE IN ANY

5 OF THIS PROCESS, SO I JUST READ ALL THESE DOCUMENTS

6 KIND OF IN RETROSPECT. AND I'M JUST AMAZED AT HOW

7 SUCCESSFUL YOU ALL HAVE BEEN AT CHANGING SOME VERY

8 CONCERNING THINGS INTO THINGS THAT AT THE END OF THE

9 DAY REALLY ARE POSITIVE FOR US OR THINGS THAT ARE

10 FAIRLY NEUTRAL FOR US. SO I WOULD JUST CONGRATULATE

11 THE WHOLE TEAM FOR DEALING WITH THIS SO ADEPTLY.

12 CHAIRMAN KLEIN: SO IF THERE ARE NO OTHER

13 COMMENTS, A RESOLUTION WOULD BE A -- A MOTION WOULD

14 BE IN ORDER.

15 MR. TORRES: MR. CHAIRMAN, I MOVE THAT WE

16 SUPPORT SB 1064 IN ITS CURRENT FORM, BUT RESERVE THE

17 RIGHT TO REVIEW FOR TECHNICAL PROFICIENCY.

18 CHAIRMAN KLEIN: I WOULD TAKE IT, SENATOR

19 TORRES, THAT YOU'RE ALSO RESERVING THE RIGHT TO

20 CHANGE THAT POSITION IF, IN FACT, THE BILL WERE TO

21 BE CHANGED UNEXPECTEDLY AS IT MOVES THROUGH THE

22 LEGISLATURE.

23 MR. TORRES: I DON'T THINK WE NEED TO SAY

24 THAT, BUT THAT'S INHERENT IN ANY RESOLUTION TO

25 SUPPORT.




19

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 CHAIRMAN KLEIN: GREAT.

2 MS. GIBBONS: I SECOND ART'S MOTION.

3 MS. SAMUELSON: QUESTION FOR COUNSEL.

4 THIS IS JOAN. FOR THOSE OF US WHOSE COMPENSATION IS

5 AFFECTED BY THIS, WE PROBABLY SHOULD HAVE SOME

6 RECUSALS, RIGHT?

7 MR. HARRISON: JOAN, THIS BILL DOESN'T

8 DIRECTLY AFFECT YOUR COMPENSATION. THE BOARD WOULD

9 HAVE TO ACT IN ORDER TO DO THAT. ALL THIS DOES IS

10 TO GIVE THE BOARD AUTHORITY TO DO SO.

11 MS. SAMUELSON: OKAY.

12 CHAIRMAN KLEIN: BUT GOOD QUESTION, JOAN.

13 WE ALWAYS HAVE TO BE VIGILANT ON THOSE MATTERS.

14 MS. SAMUELSON: YEAH. I ALMOST HAD MY

15 FIRST CONFLICT OF INTEREST. ALMOST.

16 CHAIRMAN KLEIN: ALL RIGHT. SO, MELISSA

17 KING, COULD YOU -- WELL, FIRST OF ALL, HAVE WE HAD

18 ANY COMMENT FROM THE PUBLIC AT ANY OF THE SITES?

19 ARE THERE ANY MEMBERS OF THE PUBLIC WHO WOULD LIKE

20 TO ADDRESS THIS?

21 MS. KING: WE HAVE ONE MEMBER OF THE

22 PUBLIC HERE IN SAN FRANCISCO, DON REED, WHO WOULD

23 LIKE TO MAKE A COMMENT.

24 MR. REED: THIS IS GREAT. IT ANSWERS SOME

25 NEEDS OF CIRM STAFFING. AS ANY COMPROMISE, THERE'S




20

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 THINGS I WOULD REMOVE. I REALLY DON'T SEE A NEED

2 FOR YET ANOTHER LAYER OF AUDITING, BUT I REGARD THAT

3 MORE AS A MINOR ANNOYANCE THAT WILL TAKE UP STAFF

4 TIME AND JUST ONE MORE WAY OF SHOWING THAT CIRM IS

5 DOING A FANTASTIC JOB. BUT BASICALLY THIS IS A GOOD

6 THING. I THINK THE PATIENT ADVOCACY COMMUNITY CAN

7 SUPPORT IT.

8 CHAIRMAN KLEIN: ALL RIGHT. ANY OTHER

9 COMMENTS FROM AROUND THE STATE FROM THE PUBLIC? ARE

10 THERE ANY LEGISLATIVE MEMBERS THAT ARE AT ANY OF THE

11 LOCATIONS?

12 MR. TORRES: JUST EX.

13 CHAIRMAN KLEIN: OKAY. ALL RIGHT. AND

14 AGAIN, I THINK WE SHOULD THANK SENATOR ALQUIST AND

15 HER STAFF AND SENATOR DARRELL STEINBERG AND HIS

16 STAFF FOR THEIR REALLY ENGAGED AND COMMITTED

17 INVOLVEMENT, AND WE SHOULD THANK ART TORRES FOR

18 LEADING THIS AND DUANE FOR HIS TREMENDOUS

19 INVOLVEMENT.

20 AND I WOULD SAY THAT IN THIS PROCESS I

21 PERSONALLY VISITED SOME, IN ADDITION TO SENATOR

22 ALQUIST, SOME OF THE REPUBLICAN REPRESENTATIVES.

23 AND DUANE HAS AS WELL. AND I THINK WE HAVE SOME

24 BIPARTISAN LEVEL OF SUPPORT FOR WHAT WE'RE DOING

25 HERE.




21

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MR. TORRES: PLUS SENATOR KEHOE AS CHAIR

2 OF THE APPROPRIATIONS COMMITTEE AND SENATOR FLORES

3 AND THEIR STAFFS.

4 CHAIRMAN KLEIN: ABSOLUTELY. ABSOLUTELY.

5 SENATOR FLORES WAS CERTAINLY VERY IMPORTANT AT THE

6 BEGINNING OF THIS PROCESS TO GET THE BASIC CONCEPT

7 OF THE AGREEMENTS AND THE FORMAL AGREEMENTS THAT

8 WOULD MOVE FORWARD. SO WE THANK HIM ESPECIALLY

9 ALONG WITH SENATOR KEHOE AND ALL OF DUANE'S WORK

10 WITH HER.

11 MR. TORRES: YES.

12 CHAIRMAN KLEIN: ALL RIGHT. MELISSA,

13 COULD YOU CALL THE ROLL, PLEASE.

14 MS. KING: I WILL DO THAT AND IT MAY BE

15 THE CASE THAT WE'RE WAITING FOR ONE MORE MEMBER TO

16 JOIN. IT'S POSSIBLE THAT INDIVIDUAL HAS JOINED AND

17 WE DIDN'T NOTICE. SO I'LL GO THROUGH THE ROLL AND

18 WE'LL SEE.

19 RICARDO AZZIZ.

20 DR. AZZIZ: IN FAVOR.

21 MR. TORRES: AND SECONDED BY LEEZA

22 GIBBONS.

23 MS. KING: SECONDED BY LEEZA. THANK YOU.

24 THANK YOU. FOR THE RECORD.

25 ROBERT BIRGENEAU.




22

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 DR. BIRGENEAU: YES.

2 MS. KING: FLOYD BLOOM.

3 DR. BLOOM: YES.

4 MS. KING: WILLIAM BRODY.

5 DR. BRODY: AYE.

6 MS. KING: DR. LEVIN.

7 DR. LEVIN: AYE.

8 MS. KING: LEEZA GIBBONS.

9 MS. GIBBONS: YES.

10 MS. KING: GERALD LEVEY.

11 DR. LEVEY: YES.

12 MS. KING: TED LOVE.

13 DR. LOVE: YES.

14 MS. KING: ED PENHOET.

15 DR. PENHOET: YES.

16 MS. KING: FRANCISCO PRIETO.

17 DR. PRIETO: AYE.

18 MS. KING: ROBERT QUINT. JEANNIE FONTANA.

19 DR. FONTANA: YES.

20 MS. KING: DUANE ROTH.

21 MR. ROTH: YES.

22 MS. KING: DAVID SERRANO-SEWELL. JOAN

23 SAMUELSON.

24 MS. SAMUELSON: YES.

25 MR. SERRANO-SEWELL: DAVID SERRANO-SEWELL




23

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 IS A YES.

2 MS. KING: THANK YOU. JEFF SHEEHY.

3 MR. SHEEHY: YES.

4 MS. KING: JON SHESTACK.

5 MR. SHESTACK: YES.

6 MS. KING: OSWALD STEWARD. AND ART

7 TORRES.

8 MR. TORRES: AYE.

9 MS. KING: ROBERT KLEIN.

10 CHAIRMAN KLEIN: YES.

11 MS. KING: WE ARE STILL, HOWEVER, ONE

12 SHORT.

13 CHAIRMAN KLEIN: SO WHAT I'D LIKE TO DO IS

14 LEAVE THIS ROLL CALL OPEN WHILE MAYBE SOME OF THE

15 SUPPORTING STAFF OF MELISSA COULD MAKE A CALL. AND

16 THEN I'D LIKE TO MOVE ON TO THE SECOND ITEM ON THE

17 AGENDA IF WE COULD.

18 MS. KING: WHO JUST JOINED?

19 DR. QUINT: DR. QUINT.

20 MS. KING: GREAT. THANK YOU SO MUCH,

21 DR. QUINT. AND THANKS TO AMY FOR MAKING THAT

22 POSSIBLE.

23 SO I WOULD REQUEST THAT JAMES HARRISON,

24 LEGAL COUNSEL, WOULD JUST VERY BRIEFLY GO THROUGH

25 THE MOTION THAT'S ON THE TABLE FOR DR. QUINT, AND




24

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 THEN, DR. QUINT, WE CAN GET YOUR VOTE AND MOVE

2 QUICKLY TO THE PROPOSED ADDITIONAL AGENDA ITEM SO

3 THAT EVERYBODY CAN GO BACK TO OTHER BUSINESS THIS

4 MORNING.

5 CHAIRMAN KLEIN: AND, DR. QUINT, THE

6 MOTION THAT IS GOING TO BE REVIEWED HERE FOR YOU BY

7 JAMES HARRISON IS SUPPORTED BY THE EXECUTIVE

8 COMMITTEE. AND THERE IS A ROLL CALL IN PROCESS

9 WHERE ALL OF THE VOTES THUS FAR HAVE BEEN POSITIVE.

10 MS. KING: WHO JUST JOINED?

11 CHAIRMAN KLEIN: LET ME SAY TO THE OTHER

12 MEMBERS ON THE CALL, WE DO HAVE ANOTHER ITEM ON THIS

13 AGENDA. SO PLEASE STAY WITH US. WE'LL NEED A

14 TWO-THIRDS VOTE TO ADD IT TO THE AGENDA FORMALLY.

15 MR. HARRISON: GOOD MORNING, DR. QUINT.

16 THE MOTION THAT'S ON THE TABLE IS TO SUPPORT SENATE

17 BILL NO. 1064, BUT TO RESERVE THE RIGHT TO REVIEW

18 THE BILL FOR TECHNICAL PROFICIENCY. THE BILL, IN

19 SUMMARY, WOULD ELIMINATE THE 50-EMPLOYEE CAP WHILE

20 REQUIRING CIRM TO REMAIN WITHIN THE 6-PERCENT CAP ON

21 ADMINISTRATIVE EXPENDITURES. IT WOULD PERMIT THE

22 BOARD TO PROVIDE REASONABLE COMPENSATION TO PATIENT

23 ADVOCATES FOR THEIR SERVICE ON THE WORKING GROUPS,

24 AND IT WOULD CODIFY CERTAIN PRACTICES AND

25 REGULATIONS THAT ARE ALREADY IN EFFECT WHILE




25

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MAINTAINING THE AGENCY'S FLEXIBILITY TO MAKE CHANGES

2 IN THE FUTURE.

3 AND THE QUESTION ON THE TABLE TO YOU IS

4 WHETHER YOU SUPPORT OR OPPOSE THE MOTION.

5 DR. QUINT: YES. I HAVE IT RIGHT IN FRONT

6 OF ME HERE. YES, I DO SUPPORT IT.

7 MR. HARRISON: THANK YOU.

8 MS. KING: THANK YOU, DR. QUINT. AND WITH

9 THAT, CHAIRMAN KLEIN, IF YOU COULD MOVE TO THE

10 PROPOSED ADDITIONAL AGENDA ITEM, THAT WOULD BE

11 GREAT. THANK YOU.

12 FOR THE RECORD THAT MOTION CARRIES.

13 CHAIRMAN KLEIN: SO, MR. HARRISON, COULD

14 YOU INTRODUCE THE ADDITIONAL PROPOSED AGENDA ITEM.

15 AND, AGAIN, IT WILL TAKE A TWO-THIRDS VOTE TO PUT

16 THIS FORMALLY ON THE AGENDA. SO THEN THE SECOND

17 VOTE WOULD BE ON ITS APPROVAL OR DENIAL. MR.

18 HARRISON.

19 MR. HARRISON: AS MOST OF YOU KNOW, THE

20 INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH WILL BE

21 HOLDING ITS ANNUAL MEETING HERE IN SAN FRANCISCO IN

22 JUNE. THE PROPOSAL THAT IS ON THE TABLE IS AN ITEM

23 THAT WOULD PERMIT THE BOARD TO AUTHORIZE A

24 CONFERENCE GRANT TO THE INTERNATIONAL SOCIETY FOR

25 STEM CELL RESEARCH FOR THE PURPOSES OF DEFRAYING THE




26

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 REGISTRATION FEES AND INCIDENTAL COSTS FOR CIRM

2 TRAINING GRANT PARTICIPANTS, BRIDGES TO STEM CELL

3 RESEARCH MASTER'S DEGREE CANDIDATES, AND POST DOCS

4 AND GRADUATE STUDENTS ON CIRM-FUNDED RESEARCH GRANTS

5 SO THAT THEY COULD PARTICIPATE IN THIS CONFERENCE,

6 WHICH UNFORTUNATELY DOESN'T TAKE PLACE IN CALIFORNIA

7 EVERY YEAR.

8 IN ORDER TO CONSIDER THIS ITEM, THE BOARD

9 HAS TO MAKE A DETERMINATION THAT THE NEED FOR ACTION

10 ON THIS ITEM CAME TO THE BOARD'S ATTENTION AFTER THE

11 AGENDA WAS POSTED AND THAT IT'S NECESSARY TO TAKE

12 ACTION ON THIS ITEM NOW BEFORE THE NEXT REGULARLY

13 SCHEDULED BOARD MEETING.

14 CHAIRMAN KLEIN: SO, FIRST OF ALL, SO THAT

15 WE KNOW WHERE WE ARE, COULD WE DO A VERY QUICK ROLL

16 CALL TO SEE IF WE LOST SOMEONE WHEN WE HEARD THE

17 SOUND OF POTENTIALLY SOMEONE SIGNING OFF, MELISSA.

18 SO AS A LEAD-TIME ITEM, IF WE HAVE LOST SOMEONE, WE

19 COULD GET SOMEONE TO CALL THEM.

20 MS. KING: RICARDO AZZIZ. ARE YOU STILL

21 PRESENT, DR. AZZIZ?

22 DR. AZZIZ: I AM.

23 MS. KING: ROBERT BIRGENEAU.

24 DR. BIRGENEAU: YES.

25 MS. KING: FLOYD BLOOM.




27

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 DR. BLOOM: YES.

2 MS. KING: WILLIAM BRODY.

3 DR. BRODY: HERE.

4 MS. KING: JACOB LEVIN.

5 DR. LEVIN: HERE.

6 MS. KING: LEEZA GIBBONS.

7 MS. GIBBONS: STILL HERE.

8 MS. KING: BOB KLEIN.

9 CHAIRMAN KLEIN: YES.

10 MS. KING: GERALD LEVEY. DR. LEVEY, ARE

11 YOU STILL WITH US? I'LL COME BACK TO DR. LEVEY. I

12 KNOW HE HAD ONE THING HE NEEDED TO DO CLOSE TO THE

13 END OF THIS CALL. HE MAY HAVE HAD TO STEP OUT FOR A

14 MOMENT.

15 TED LOVE.

16 DR. LOVE: HERE. BUT I HAVE A HARD STOP

17 AT NINE.

18 MS. KING: ED PENHOET.

19 DR. PENHOET: HERE.

20 MS. KING: PHIL PIZZO. FRANCISCO PRIETO.

21 DR. PRIETO: HERE.

22 MS. KING: ROBERT QUINT.

23 DR. QUINT: PRESENT.

24 MS. KING: JEANNIE FONTANA.

25 DR. FONTANA: PRESENT.




28

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MS. KING: DUANE ROTH.

2 MR. ROTH: HERE.

3 MS. KING: JOAN SAMUELSON.

4 MS. SAMUELSON: PRESENT.

5 MS. KING: DAVID SERRANO-SEWELL. JEFF

6 SHEEHY.

7 MR. SHEEHY: HERE.

8 MS. KING: JON SHESTACK.

9 MR. SHESTACK: HERE.

10 MR. SERRANO-SEWELL: DAVID IS HERE.

11 MS. KING: THANKS, DAVID. AND ART TORRES

12 IS PRESENT.

13 MR. TORRES: HERE.

14 MS. KING: SO WE MAY HAVE MOMENTARILY LOST

15 DR. LEVEY, BUT UNFORTUNATELY WE DON'T HAVE --

16 DR. LEVEY: I'M HERE.

17 MS. KING: THANKS, DR. LEVEY. I SUGGEST

18 WE MOVE FORWARD AS QUICKLY AS WE CAN. SEVERAL

19 PEOPLE HAVE A HARD STOP AT NINE, AND WE DON'T

20 ACTUALLY HAVE THAT MANY OTHER OPTIONS.

21 CHAIRMAN KLEIN: GREAT. I THINK THIS IS

22 GOING TO BE A FAIRLY SUCCINCT DISCUSSION. SO WE

23 SHOULD BE ABLE TO OPERATE WITHIN THOSE LIMITS.

24 MR. ROTH: BOB, I'LL MAKE THE MOTION THAT

25 WE NEED TO CONSIDER THIS AT THE PRESENT TIME.




29

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MR. SHESTACK: SECOND.

2 CHAIRMAN KLEIN: OKAY. THERE'S A MOTION

3 AND A SECOND.

4 MS. KING: SECOND WAS FROM JON SHESTACK.

5 CHAIRMAN KLEIN: IS THERE PUBLIC COMMENT

6 ON THE QUESTION OF WHETHER TO CONSIDER IT? ANY

7 BOARD COMMENT ON THE QUESTION OF WHETHER TO CONSIDER

8 IT? PLEASE CALL THE ROLL CALL ON WHETHER WE WILL

9 CONSIDER THIS.

10 MS. KING: RICARDO AZZIZ.

11 DR. AZZIZ: YES.

12 MS. KING: ROBERT BIRGENEAU.

13 DR. BIRGENEAU: YES.

14 MS. KING: FLOYD BLOOM.

15 DR. BLOOM: YES.

16 MS. KING: WILLIAM BRODY.

17 DR. BRODY: YES.

18 MS. KING: JACOB LEVIN.

19 DR. LEVIN: YES.

20 MS. KING: LEEZA GIBBONS.

21 MS. GIBBONS: YES.

22 MS. KING: BOB KLEIN.

23 CHAIRMAN KLEIN: YES.

24 MS. KING: GERALD LEVEY.

25 DR. LEVEY: YES.




30

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MS. KING: TED LOVE.

2 DR. LOVE: YES.

3 MS. KING: ED PENHOET.

4 DR. PENHOET: YES.

5 MS. KING: FRANCISCO PRIETO.

6 DR. PRIETO: YES.

7 MS. KING: ROBERT QUINT.

8 DR. QUINT: YES.

9 MS. KING: JEANNIE FONTANA.

10 DR. FONTANA: YES.

11 MS. KING: DUANE ROTH.

12 MR. ROTH: YES.

13 MS. KING: JOAN SAMUELSON.

14 MS. SAMUELSON: YES.

15 MS. KING: DAVID SERRANO-SEWELL.

16 MR. SERRANO-SEWELL: YES.

17 MS. KING: JEFF SHEEHY.

18 MR. SHEEHY: YES.

19 MS. KING: JON SHESTACK.

20 MR. SHESTACK: YES.

21 MS. KING: AND ART TORRES.

22 MR. TORRES: AYE.

23 MS. KING: THAT MOTION CARRIES.

24 CHAIRMAN KLEIN: ALL RIGHT. SO THIS

25 PARTICULAR ITEM AROSE. THERE WAS SOME DISCUSSION




31

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 WITH BOARD MEMBERS AND THERE WAS DISCUSSION WITH

2 MEMBERS OF THE SCIENTIFIC COMMUNITY WHO POINTED OUT

3 THAT, IN FACT, THERE WERE NEW ENTRANTS INTO THE STEM

4 CELL FIELD, EXTREMELY TALENTED YOUNG CIRM SCHOLARS.

5 THEY WERE MASTER'S CANDIDATES IN THE BRIDGE PROGRAM

6 WHO THEY WERE TRYING TO MOTIVATE AT THEIR

7 INSTITUTIONS TO GO ON FOR POSTDOCTORAL WORK OR TO

8 STAY IN THE FIELD IN HIGHLY TECHNICAL POSITIONS.

9 AND THERE ARE POST DOCS AND GRAD STUDENTS WHO ARE AT

10 THE VERY JUNIOR SCALE OF THE SCIENTIFIC GRANTS WE'VE

11 APPROVED WHERE THERE IS NOT ANY ALLOCATION REMAINING

12 OR THERE WAS NEVER ANY ALLOCATION FOR TRAINING GRANT

13 FUNDS -- EXCUSE ME -- FOR TRAVEL AND CONFERENCE

14 FUNDS.

15 THERE ARE FUNDS IN THE CIRM TRAINING

16 GRANTS FOR TRAVEL AT THE END OF THE YEAR, AT THE END

17 OF THEIR TWO-YEAR PERIOD. THEY MAY HAVE EXHAUSTED

18 THOSE BY THE TIME THEY COME UP FOR THIS

19 INTERNATIONAL CONFERENCE. AS MR. HARRISON

20 INDICATES, IT MAY BE FIVE YEARS OR MORE BEFORE

21 THERE'S ANOTHER CONFERENCE IN CALIFORNIA WHERE THESE

22 JUNIOR MEMBERS WOULD BE ABLE TO ATTEND AND GET THE

23 BENEFIT OF THE LEARNING EXPERIENCE EXPOSED TO SOME

24 OF THE BEST MINDS IN THE WORLD.

25 JAMES, WOULD YOU LIKE TO GO THROUGH THE




32

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 DETAILS IN THIS PROPOSAL, PLEASE.

2 MR. HARRISON: SURE. THE PROPOSAL IS TO

3 ALLOCATE UP TO $226,500 TO ISSCR IN THE FORM OF A

4 CONFERENCE GRANT TO UNDERWRITE THE PARTICIPATION OF

5 UP TO 300 YOUNG RESEARCHERS AND STUDENTS FROM ACROSS

6 THE STATE. THE FUNDS WOULD BE ALLOCATED TO THE

7 ISSCR WHICH WOULD ADMINISTER THE PROGRAM AND WHICH

8 WOULD RETURN ANY UNUSED FUNDS TO THE AGENCY. THESE

9 FUNDS WOULD BE IN ADDITION TO THE FUNDS THE BOARD

10 HAS PREVIOUSLY ALLOCATED FOR THE CIRM CONFERENCE

11 GRANT PROGRAM.

12 IN TERMS OF ELIGIBILITY, THE PROGRAM WOULD

13 BE OPEN TO INDIVIDUALS WHO HAVE NOT YET REGISTERED

14 FOR ISSCR AND WHO FALL INTO ONE OF THREE CATEGORIES.

15 FIRST, CIRM SCHOLARS; THAT IS, THE INDIVIDUALS ARE

16 PARTICIPANT STUDENTS IN ONE OF CIRM'S TRAINING GRANT

17 PROGRAMS. TWO, BRIDGES TO STEM CELL RESEARCH

18 PARTICIPANTS, WHICH WOULD BE LIMITED TO MASTER'S

19 DEGREE CANDIDATES IN ONE OF CIRM'S BRIDGES PROGRAMS.

20 AND THIRD, CIRM RESEARCH GRANT PARTICIPANTS, WHICH

21 WOULD BE LIMITED TO POST DOCS AND GRADUATE STUDENTS

22 WHO ARE IDENTIFIED AS KEY PERSONNEL ON A CIRM-FUNDED

23 RESEARCH GRANT AT A NONPROFIT INSTITUTION.

24 THE SUBMISSION PROCESS WHICH WOULD BE

25 HANDLED BY ISSCR WHICH WOULD REQUIRE ELIGIBLE




33

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 INDIVIDUALS TO SUBMIT A ONE-PAGE REQUEST EITHER

2 SIGNED BY THEIR PROGRAM DIRECTOR OR CIRM SCHOLARS

3 AND BRIDGES STUDENTS OR THE PRINCIPAL INVESTIGATOR

4 FOR KEY PERSONNEL ON A CIRM-FUNDED (INTERRUPTION).

5 THERE WOULD BE AN INSTITUTIONAL LIMIT. NO MORE THAN

6 15 AWARDS WOULD BE MADE TO INDIVIDUALS ASSOCIATED

7 WITH A PARTICULAR INSTITUTION.

8 IN TERMS OF GEOGRAPHIC DISTRIBUTION, THE

9 FUNDS WOULD BE ALLOCATED TO NO MORE THAN 120

10 INDIVIDUALS IN NORTHERN CALIFORNIA DEFINED AS UC

11 SANTA CRUZ AND NORTH, AND NO MORE THAN 180 STUDENTS

12 FROM SOUTHERN CALIFORNIA DEFINED AS SOUTH OF UC

13 SANTA CRUZ, WHICH GENERALLY REFLECTS THE

14 DISTRIBUTION OF GRANTS.

15 THE FUNDING WOULD BE FOR STUDENTS FROM

16 NORTHERN CALIFORNIA 350 TO PAY THE REGISTRATION FEE

17 AND $150 FOR TRAVEL AND INCIDENTALS FOR A TOTAL OF

18 $500. AND FOR PARTICIPANTS OF SOUTHERN CALIFORNIA,

19 THEY WOULD BE ELIGIBLE TO RECEIVE $350 FOR THE

20 REGISTRATION FEE AND $575 FOR TRAVEL AND INCIDENTALS

21 FOR A TOTAL OF $925.

22 CHAIRMAN KLEIN: SO THE REGULAR

23 REGISTRATION TO THIS CONFERENCE IS CLOSED SO THAT

24 ANYONE WHO HAD IDENTIFIED FUNDS BEFORE THIS BECAME

25 AVAILABLE HAS USED THOSE FUNDS. IT'S A




34

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 SELF-SELECTION PROCESS WHERE THOSE WHO DID NOT HAVE

2 AVAILABLE FUNDS ARE NOW ELIGIBLE. NO ONE WAS AWARE

3 THAT THIS PROGRAM MIGHT EXIST, AND IT WILL NOT

4 UNLESS THE BOARD APPROVES IT TODAY. SO THEY HAD NO

5 WAY OF ANTICIPATING OR GAMING THE SYSTEM. WE EXPECT

6 THAT THERE ARE, HOWEVER, MANY INDIVIDUALS WHO WOULD

7 LIKE TO GO AND WOULD BENEFIT GREATLY IF THIS

8 ASSISTANCE WERE MADE AVAILABLE.

9 FOR THE PURPOSES OF DISCUSSION, IS THERE

10 ANYONE WHO WOULD LIKE TO MAKE A MOTION IN SUPPORT OF

11 THIS PROPOSAL?

12 DR. PRIETO: I'LL MAKE A MOTION. I'LL

13 MOVE THAT WE SUPPORT THIS PROPOSAL.

14 DR. LOVE: SECOND.

15 CHAIRMAN KLEIN: AND THERE'S A QUESTION

16 FROM A MEMBER.

17 DR. LEVIN: THIS IS JACOB LEVIN FROM

18 IRVINE. BOB, I THINK THIS IS A GREAT IDEA AND JUST

19 THE KIND OF PROGRAM THAT CIRM SHOULD SUPPORT TO

20 EXTEND OUR TRAINING AND TO BRING NEW PEOPLE INTO THE

21 FIELD.

22 I HAVE A QUESTION ABOUT THE RESTRICTION TO

23 PEOPLE WHO HAVEN'T YET REGISTERED. IT ACTUALLY

24 DOESN'T SEEM TO ME QUITE FAIR TO BASICALLY REWARD

25 THE PEOPLE WHO HAVEN'T MADE THE FINANCIAL COMMITMENT




35

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 WHILE THERE MAY BE STUDENTS WHO HAVE REGISTERED, BUT

2 ARE PUTTING THEMSELVES OR THEIR PI'S UNDER SOME SORT

3 OF SIGNIFICANT FINANCIAL STRESS, BUT WHO ARE FOLKS

4 SO COMMITTED THAT THEY DECIDED IT WOULD BE WORTH IT

5 TO GO ANYWAY. IT SEEMS LIKE THERE'S A SIGNIFICANT

6 AMOUNT OF FUNDS AVAILABLE, AND IT MIGHT BE

7 WORTHWHILE TO OPEN IT UP TO ALL POTENTIAL

8 APPLICANTS, INCLUDING THOSE THAT HAVE ALREADY

9 REGISTERED, GIVING THEM THE OPPORTUNITY TO BE

10 REIMBURSED FOR THE COST THAT THEY HAVE ALREADY PUT

11 OUT OR AT LEAST COMMITTED TO PUTTING OUT.

12 CHAIRMAN KLEIN: WITH THE LEVEL OF TRAVEL

13 AND REIMBURSEMENTS, PARTICULARLY FOR PEOPLE FROM

14 SOUTHERN CALIFORNIA, EVEN INDIVIDUALS ATTENDING

15 UNDER THIS PROGRAM WILL HAVE TO POTENTIALLY

16 CONTRIBUTE SOME OF THEIR OWN FUNDS OR FIND SOME

17 SUPPLEMENTAL FUNDS UNLESS THEY'RE GOING TO STAY WITH

18 FRIENDS IN THE BAY AREA, WHICH THEY MAY WELL DO.

19 SO IT IS IMPORTANT, HOWEVER, TO NOTE THAT

20 THE REGISTRATION WITH THE REDUCED COST WAS CLOSED.

21 THAT $350 STUDENT REGISTRATION WAS CLOSED, AND I WAS

22 ABLE TO TALK TO ISSCR AND HAVE THEM AGREE THAT SINCE

23 ANYONE WHO COULD HAVE AFFORDED IT AHEAD OF TIME DID

24 REGISTER, THEY WOULD WITH THIS CONDITION MAKE IT

25 AVAILABLE TO THOSE WHO DID NOT HAVE ANY ACCESS TO




36

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 FUNDS AND WOULD EXTEND THE $350 STUDENT REGISTRATION

2 PROGRAM FOR THIS LIMITED SPECIFIC GROUP.

3 IT'S AN ISSUE WHERE THE RECOMMENDATION IS

4 THAT WE TRY AND UTILIZE IT ON THIS BASIS. IT WILL

5 EXPAND SIGNIFICANTLY THOSE WHO CAN ATTEND, AND WE DO

6 REALIZE THAT SOME WHO REGISTERED EARLIER ARE MAKING

7 SOME SACRIFICES THEMSELVES.

8 DR. PENHOET: RELATED QUESTION. IF MORE

9 STUDENTS AND POST DOCS, ETC., APPLY FOR THESE

10 MONIES, THEN THEY HAVE AVAILABLE FUNDS FROM THIS

11 GRANT THAT WE'RE GOING TO MAKE, WHO WILL MAKE THE

12 DECISION ABOUT WHO GETS TO COME AND WHO DOES NOT GET

13 TO COME? AND WHAT WILL THE CRITERIA BE FOR THE

14 PETITION THEY MAKE?

15 CHAIRMAN KLEIN: IT'S BEEN PROPOSED --

16 WELL, FIRST OF ALL, THE FACULTY MEMBER IN CHARGE OF

17 THE PROGRAM OR IN THE CASE OF RESEARCH TEAMS THE PI

18 OR CO-PI IN CHARGE OF THE TEAM IS TO WRITE THIS

19 ONE-PARAGRAPH RECOMMENDATION AND VERIFICATION THAT

20 THEY ARE A PART OF ONE OF THE QUALIFIED CATEGORIES.

21 AND WITH THOSE RECOMMENDATIONS, IT'S ON A FIRST

22 COME, FIRST-SERVED BASIS BY INSTITUTION.

23 NOW, INSTITUTIONS CAN DECIDE THEMSELVES

24 WHICH RECOMMENDATIONS THEY'RE GOING TO SUBMIT. BUT

25 IT IS A FIRST COME, FIRST-SERVED BASIS BY




37

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 INSTITUTION UP TO THE CAP PER INSTITUTION.

2 ARE THERE ADDITIONAL QUESTIONS?

3 DR. LEVIN: ARE YOU SAYING THAT ISSCR

4 WOULD NOT HONOR THIS EXTENSION OF THE $350

5 REGISTRATION RATE IF WE ADAPTED THIS PROGRAM TO

6 COVER BOTH PEOPLE WHO WERE REGISTERED AND PEOPLE WHO

7 WEREN'T?

8 CHAIRMAN KLEIN: WELL, THAT'S NOT THE

9 BASIS ON WHICH I WAS ABLE TO NEGOTIATE THE

10 EXTENSION, DR. LEVIN. AND I WOULD HAVE TO GO BACK

11 TO THEM TO FIND OUT IF THEY WOULD DO SO, AND WE DO

12 NOT HAVE ANOTHER BOARD MEETING TO CONSIDER THIS IN

13 THE INTERIM.

14 DR. PRIETO: GIVEN THE TIME CONSTRAINTS, I

15 THINK THAT WE WOULD BE ASKING THEM TO -- GOING BACK

16 TO THEM AND ASKING THEM TO CHANGE THE TERMS OF THE

17 AGREEMENT, AND I DON'T THINK THAT'S PRACTICAL.

18 DR. LEVIN: MY QUESTION WAS JUST COULD

19 WE -- IF WE VOTED FOR A FRIENDLY AMENDMENT TO EXTEND

20 IT TO PEOPLE WHO HAD ALREADY REGISTERED, WOULD THAT

21 REQUIRE ADDITIONAL ACTION. AND IT SOUNDS LIKE THE

22 ANSWER IS YES. SO WE DON'T HAVE THAT OPTION.

23 CHAIRMAN KLEIN: RIGHT. ALL RIGHT. IS

24 THERE -- ARE THERE COMMENTS FROM ANY MEMBERS OF THE

25 PUBLIC?




38

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MS. KING: YES. WE HAVE ONE FROM A MEMBER

2 OF THE PUBLIC. WE HAVE A COMMENT HERE IN SAN

3 FRANCISCO FROM PRESIDENT ALAN TROUNSON.

4 CHAIRMAN KLEIN: DR. TROUNSON, I WAS

5 IMMEDIATELY GOING TO CALL ON YOU, BUT PLEASE.

6 DR. TROUNSON: THIS IS A VERY INTERESTING

7 PROPOSAL, AND IT'S REALLY COME FROM THE CHAIRMAN

8 ORIGINALLY. I THINK IT WILL PRODUCE SOME ISSUES OF

9 PARITY. I THINK IT'S JUST IDENTIFIED. BUT THEY'RE

10 GOING TO HAVE TO LIVE WITH THAT BECAUSE ISSCR ARE

11 GOING TO MANAGE THESE FUNDS AND AS SUCH WILL NOT

12 WANT TO REENTER ANY KIND OF NEGOTIATIONS WITH PEOPLE

13 WHO HAVE ALREADY REGISTERED. I THINK IT WOULD BE

14 FAIR TO SAY THAT MANAGEMENT WAS KIND OF LUKE WARM TO

15 THIS, AND I'M REPRESENTING VIEWS BROADLY ACROSS THE

16 SCIENCE GROUP RATHER THAN ANY INDIVIDUAL, THAT

17 NORMALLY WHAT HAPPENS IS THAT THE BEST PEOPLE, THE

18 BEST SCIENTISTS AND THE ONES THAT HAVE PROGRESSED

19 THE BEST GET THE OPPORTUNITIES TO GO TO THESE

20 MEETINGS. THOSE THAT ARE VERY EARLY DON'T REALLY

21 BENEFIT VERY MUCH FROM THIS EXPOSURE.

22 THEY NEED TO BE IN THEIR STUDIES FOR AT

23 LEAST A YEAR OR A YEAR AND A HALF BEFORE THERE'S

24 REALLY ANY BENEFIT. AND WE ARE PROBABLY EXTENDING

25 THOSE BENEFITS DOWN TO THESE PEOPLE.




39

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 SO THE RETURN ON A QUARTER OF A MILLION

2 DOLLARS IN RESPECT TO AT LEAST SOME OF MANAGEMENT'S

3 STAFF IS RATHER DUBIOUS, BUT IT IS VERY CLEAR THAT

4 THERE'S A BENEFIT FOR ISSCR. LET ME BE CLEAR ABOUT

5 THAT. THEY WOULD HAVE -- THEY WOULD STRONGLY

6 BENEFIT FROM THIS. SO THERE'S GOOD REASON WHY

7 THEY'D WANT TO DO IT.

8 BUT I PERSONALLY AM SUPPORTIVE OF THIS,

9 BUT I REALLY WANTED TO BRING MANAGEMENT'S LUKE WARM

10 FEELING TO THE BOARD. IT WOULDN'T BE FAIR IF I

11 HADN'T DONE THAT BECAUSE I THINK THERE ARE -- THIS

12 IS AN UNUSUAL, THIS IS A VERY UNUSUAL MOVE VERY LATE

13 IN PRACTICE AND WILL BRING SOME ISSUES FROM SOME OF

14 OUR SENIOR RESEARCHERS THAT IT WASN'T SORT OF

15 PRETHOUGHT OF INITIALLY.

16 CHAIRMAN KLEIN: AND I THINK IN THE

17 INTEREST OF FULLY DISCUSSING IT, I APPRECIATE YOUR

18 COMMENTS. I TOOK THIS CONCERN FROM OUR -- SOME OF

19 OUR SCIENTIFIC STAFF TO THE ISSCR, SPECIFICALLY

20 TALKED TO IRV WEISSMAN, WHO IS THE PRESIDENT OF THE

21 ISSCR ABOUT THIS. AND HIS VIEW WAS THAT THERE WERE

22 TREMENDOUS PEOPLE ON THE RESEARCH TEAMS THAT HE WAS

23 AWARE OF WHERE THEY WERE VERY JUNIOR ON THE TEAM,

24 DID NOT HAVE ANY BUDGET ALLOCATION FOR TRAVEL AND

25 CONFERENCES, OR IT WAS EXTREMELY LIMITED AND HAD




40

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 EXHAUSTED IT BY COMMITMENT TO A VERY NARROW

2 CONFERENCE OR SPECIALIZED CONFERENCE THAT WAS

3 DIRECTLY ON POINT WITH THEIR RESEARCH.

4 BUT HE THOUGHT THAT THEY WOULD BENEFIT

5 HUGELY FROM GOING TO THIS TYPE OF CONFERENCE. AND

6 FROM OTHER RESEARCH PEOPLE HE TALKED TO, HE THOUGHT

7 THERE WAS A GREAT DEAL OF ENTHUSIASM FOR BONDING

8 THIS. HE BELIEVED IT WOULD REALLY HELP THEM

9 CONTINUE TO RECRUIT AND HOLD THE BEST TALENT

10 POSSIBLE WHO WERE JUNIOR IN THESE TEAMS BY GIVING

11 THEM AN EXPOSURE TO THE BROAD SCOPE OF THE FIELD.

12 SO I TOOK HIS COMMENT SERIOUSLY, TRIED TO

13 FOLLOW UP ON IT, AND DR. WEISSMAN HAS A VERY BROAD

14 SPECTRUM VIEW OF FIELD, AND HIS INPUT WOULD BE

15 VALUABLE IN THE PROCESS.

16 MS. KING: AND WE HAVE TWO MINUTES UNTIL

17 WE'RE GOING TO LOSE OUR QUORUM.

18 CHAIRMAN KLEIN: OKAY. DO WE HAVE MORE

19 BOARD COMMENTS?

20 MR. SHESTACK: LET'S GO.

21 CHAIRMAN KLEIN: OKAY. CALL THE QUESTION.

22 MELISSA.

23 MS. KING: I BELIEVE THAT YOU ALREADY

24 ASKED FOR PUBLIC COMMENT, BUT IT'S BEING SUGGESTED

25 THAT MAYBE YOU SHOULD ASK FOR IT AGAIN.




41

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 CHAIRMAN KLEIN: ALL RIGHT. VERY QUICKLY,

2 IF THERE ARE PUBLIC COMMENTS.

3 MS. KING: SEEING NONE, I'LL BEGIN THE

4 ROLE.

5 RICARDO AZZIZ.

6 DR. AZZIZ: YES.

7 MS. KING: ROBERT BIRGENEAU.

8 DR. BIRGENEAU: YES.

9 MS. KING: FLOYD BLOOM.

10 DR. BLOOM: YES.

11 MS. KING: WILLIAM BRODY.

12 DR. BRODY: YES.

13 MS. KING: JACOB LEVIN.

14 DR. LEVIN: YES.

15 MS. KING: LEEZA GIBBONS.

16 MS. GIBBONS: YES.

17 MS. KING: BOB KLEIN.

18 CHAIRMAN KLEIN: YES.

19 MS. KING: GERALD LEVEY.

20 DR. LEVEY: YES.

21 MS. KING: TED LOVE.

22 DR. LOVE: YES.

23 MS. KING: ED PENHOET.

24 DR. PENHOET: YES.

25 MS. KING: FRANCISCO PRIETO.




42

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 DR. PRIETO: AYE.

2 MS. KING: ROBERT QUINT.

3 DR. QUINT: YES.

4 MS. KING: JEANNIE FONTANA.

5 DR. FONTANA: YES.

6 MS. KING: DUANE ROTH.

7 MR. ROTH: YES.

8 MS. KING: JOAN SAMUELSON.

9 MS. SAMUELSON: YES.

10 MS. KING: DAVID SERRANO-SEWELL.

11 MR. SERRANO-SEWELL: YES.

12 MS. KING: JEFF SHEEHY.

13 MR. SHEEHY: YES.

14 MS. KING: JONATHAN SHESTACK.

15 MR. SHESTACK: YES.

16 MS. KING: AND ART TORRES.

17 MR. TORRES: AYE.

18 MS. KING: AND THAT MOTION CARRIES. AND

19 THANK YOU ALL FOR BEING HERE.

20 MR. SHEEHY: COULD I ASK A QUICK QUESTION?

21 CHAIRMAN KLEIN: YEAH. I WANT TO, JEFF,

22 GET JAMES HARRISON TO GIVE A COMMENT. IN TERMS OF

23 THE PROGRAM FOR PATIENT ADVOCATES TO ATTEND, IS IT

24 MY UNDERSTANDING WE DON'T NEED A SEPARATE

25 APPROPRIATION AT THE BOARD LEVEL TO DO THAT?




43

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 MR. HARRISON: THAT'S CORRECT. MY

2 UNDERSTANDING IS THAT THAT IS BEING HANDLED

3 ADMINISTRATIVELY.

4 CHAIRMAN KLEIN: OKAY. AND I WOULD LIKE

5 TO LET THE BOARD KNOW THAT FOLLOWING UP ON A

6 PROPOSAL THAT JEFF SHEEHY MADE AT THE ORIGINAL BOARD

7 MEETING WHERE THE ISSCR WAS DISCUSSED, THERE IS A

8 SPECIAL PROGRAM FOR PATIENT ADVOCATES TO ATTEND.

9 HAVING THOSE PATIENT ADVOCATES WHO HAVE SPECIFIC --

10 WHO HAVE DEEP BACKGROUND AND INTEREST ATTEND FROM A

11 BROAD SPECTRUM OF DISEASE GROUPS PROVIDES THEM WITH

12 THE QUALITY OF INFORMATION SO THEY CAN REMAIN AS

13 HIGHLY INFORMED REPRESENTATIVES AND PUBLIC

14 DISCUSSANTS OF THE TOPIC, AND WE ARE FOLLOWING THAT

15 UP ON A PROGRAM THAT WE HAD DISCUSSED AS RECENTLY AS

16 THIS WEEKEND AND YESTERDAY.

17 AND JEFF, I'M GOING TO BE TALKING TO YOU

18 ON THE IMPLEMENTATION OF THAT.

19 MS. KING: JUST TO CLARIFY, CHAIRMAN

20 KLEIN, MAYBE YOU WANT TO --

21 CHAIRMAN KLEIN: I WOULD JUST SAY THAT IT

22 WOULD FOLLOW THE SAME PARAMETERS AS THE

23 REIMBURSEMENTS HERE, BUT A MUCH MORE LIMITED

24 PROGRAM. IT WOULD MAXIMALLY INVOLVE ABOUT A HUNDRED

25 PATIENT ADVOCATES FROM AROUND THE STATE. I WOULD




44

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 EXPECT MORE IN THE RANGE OF 50 TO 70 THAT WOULD

2 ACTUALLY PARTICIPATE, BUT A GOOD DISTRIBUTION ACROSS

3 ALL DISEASE GROUPS IS THE INTENT.

4 MR. SHEEHY: THANK YOU, BOB. THAT REALLY

5 WAS MY QUESTION BECAUSE I HAD HAD A SPECIFIC

6 COMMITMENT FROM THE VICE PRESIDENT OF THE AGENCY

7 THAT WE WOULD IMPLEMENT SUCH A PROGRAM LAST SUMMER

8 WHEN WE VOTED THROUGH FUNDS TO SUPPORT THE ISSCR

9 COMING TO CALIFORNIA. AND WE SPECIFICALLY DISCUSSED

10 ABOUT A PROGRAM, A MODEL ON SOME OF THE THINGS THAT

11 HAPPENED IN HIV. THERE ARE VARIOUS CONFERENCES

12 WHERE PATIENT ADVOCATES ARE PROVIDING SCHOLARSHIPS

13 AND SUPPORT TO ATTEND CONFERENCES. IT JUST SEEMED

14 VERY REASONABLE TO SUPPORT THE FOLKS AROUND

15 CALIFORNIA WHO HAD AN INTEREST IN OUR RESEARCH WHO

16 BASICALLY THROUGH THEIR HARD WORK ON PROP 71 MADE

17 CIRM AND ALL OF OUR ROLES HERE POSSIBLE. SO THANK

18 YOU FOR MOVING FORWARD WITH THIS AND PAYING

19 ATTENTION TO THIS. AND I'M GLAD WE DON'T NEED ANY

20 FURTHER BOARD ACTION ON THIS. THANK YOU.

21 CHAIRMAN KLEIN: OKAY. I THINK, MR.

22 HARRISON, CAN WE THANK THE BOARD?

23 MR. HARRISON: WE SURE CAN.

24 CHAIRMAN KLEIN: WE THANK THE BOARD AND WE

25 THANK THE STAFF FOR THEIR TREMENDOUS COMMITMENT, AND




45

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM



                   UNOFFICIAL, UNCERTIFIED TRANSCRIPT OF PROCEEDINGS   


1 WE THANK AGAIN THE LEADERSHIP OF ART TORRES AND

2 DUANE ROTH IN MOVING US FORWARD HERE. AND WE THANK

3 THE LEGISLATURE FOR THEIR COLLABORATION WITH US ON

4 THESE PROVISIONS.

5 MS. KING: THANKS EVERYBODY.

6 (THE MEETING WAS THEN ADJOURNED AT

7 9:05 A.M.)

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25




46

1072 BRISTOL STREET, COSTA MESA, CALIFORNIA 92626
1-800-622-6092 1-714-444-4100 EMAIL: DEPO@DEPO1.COM


Newsletter Sign-Up

Receive press releases, funding announcements or other news from CIRM.

>> Click here to sign up

Follow Us

Facebook Updates
YouTube Videos
Twitter
Flickr Images
LinkedIn
Research Blog
RSS Feeds

 

Bookmark and Share
  • Contact Us
  • Privacy Policy
  • Accessibility
  • Site Map
© 2009 California Institute For Regenerative Medicine